Malnutrition Common in Older Brazilians Hospitalized for Cancer
Most prevalent nutrition impact symptoms include no appetite, dry mouth.
General Oncology
Phase 3 Trial for Oncolytic Viral Therapy Pexa-Vec in Advanced Liver Cancer Terminated Early
Pexa-Vec, in combination with sorafenib, has failed an interim futility analysis, leading to the early termination of the trial.
Multidisciplinary Approach Maintains, Restores Fertility in Female Patients With Cancer
A report on oncofertility identifies the optimal multidisciplinary team for assuring that young patients with cancer can preserve their fertility and the options available to them for family building.
Recent Advances Offer Paths Forward for Developing Predictive Biomarkers in Cancer Immunotherapy
Recent advances in predictive biomarker development clarify how best to determine PD-L1 expression in tumor cells.
Cancer Risk From Recalled ARBs “Likely Much Lower” Than Initially Estimated, Says FDA
The FDA clarified that the risk of cancer associated with exposure to nitrosamine impurities was likely lower than what was initially assessed.
Knowing the Appropriateness of Running Noninferiority Trials in Oncology
Researches took a critical look at noninferiority trials and determined that when a new intervention is “not worse,” the possibility exists that it is not better, either.
Cancer Survivors Face Long-Term Cardiovascular Risk
Risk varies by cardiovascular outcome and site of 20 common cancers.
The Case for a 3-Tier Tumor Mutational Burden Classification Scheme to Identify Candidates for Immunotherapy
In many cancers, there are no standard cutoff points for what would be considered “TMB-low” or “TMB-high.”
Few Oncologists Suggest Health Promotion to Cancer Survivors
Oncologists expressed concern that health promotion could distress or overwhelm cancer survivors.
Out-of-Network Billing Common for Privately Insured Patients Receiving In-Network Care
Little is known about the frequency and financial repercussions of out-of-network billing, despite frequent news in the media about surprise medical bills.
Next post in General Oncology
